| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
| filingDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc42d5e6fe9f5968a3fa65cdd8fe48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50fbcb731c10f49968a8a5632cba2f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_308d65ad64c56c65743ece1884b00ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92964a2d579b5ceeca73c5ed6e11548 |
| publicationDate |
2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200060305-A |
| titleOfInvention |
Composition for Inhibiting Angiogenesis Using an Extract of Zizania Latifolia |
| abstract |
To transition the present invention is to vascular endothelial cells (Human Umbilical Vein Endothelial Cells) growth inhibition also the addition of the adhesion and suppresses the movement and increases the expression of p27 in inhibitor of cell cycle in the cell cycle G 1 phase S phase of the Disclosed is a composition for inhibiting angiogenesis using an extract of dulcis having activity such as inhibiting expression of cyclin E and cdk2 involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220125941-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115645495-A |
| priorityDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |